• Study on Trastuzumab and Pertuzumab for Patients with HER2-Positive Breast Cancer Using a Response-Adapted Strategy

    Not recruiting

    2 1 1 1
    France Germany Italy Portugal Spain
  • Study on Long-Term Safety and Effects of PTC518 for Patients with Huntington’s Disease

    Not recruiting

    2 1
    Investigated Diseases:
    Investigated Drugs:
    Austria France Germany Italy The Netherlands Spain
  • Study on Regorafenib and Nivolumab for Patients with Advanced Gastro-Oesophageal Cancer

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Investigated Drugs:
    Austria Germany Italy Spain
  • Study of LY3502970 for Adults with Obesity or Overweight and Related Health Issues

    Not recruiting

    3 1
    Slovakia Spain
  • Study Comparing Ibrutinib, Venetoclax, and Obinutuzumab for Untreated Chronic Lymphocytic Leukemia Patients

    Not recruiting

    3 1 1 1
    Investigated Diseases:
    Austria Belgium Denmark Finland Germany Ireland +5
  • Study on the Effectiveness of Bimatoprost SR for Patients with Open-Angle Glaucoma or Ocular Hypertension

    Not recruiting

    3 1 1
    Investigated Diseases:
    Investigated Drugs:
    Bulgaria Czechia Denmark Germany Ireland Italy +1
  • Study on Long-term Safety and Efficacy of Efgartigimod in Adults with Active Idiopathic Inflammatory Myopathy Using a Drug Combination

    Not recruiting

    3 1 1 1
    Austria Belgium Bulgaria Cyprus Czechia Denmark +13
  • Study of INCB099280 for Patients with Advanced Solid Tumors Who Have Not Received Immunotherapy

    Not recruiting

    2 1 1
    Investigated Drugs:
    Greece Hungary Romania
  • Study of Elranatamab for Treating Relapsed or Refractory Multiple Myeloma in Patients Previously Treated with Three Drug Classes

    Not recruiting

    2 1 1
    Investigated Drugs:
    Spain
  • Study on the Effectiveness and Safety of Secukinumab for Adults with Moderate to Severe Rotator Cuff Tendinopathy

    Not recruiting

    3 1 1
    Denmark Greece Hungary Italy Poland Spain

powered by